# Mitsubishi Group (Japan)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/mitsubishi-group-japan/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 8.5 |
| Citations | 697,429 |
| City | Tokyo |
| Country | JP |
| Description | Mitsubishi Group (Japan) is a research organisation in Tokyo, JP. OpenAlex records 9,246 works and 697,429 citations for it. 1,926 researchers list it as their most recent affiliation. |
| Homepage | https://www.mitsubishi.com |
| OpenAlex ID | https://openalex.org/I1306287861 |
| Region | Tokyo |
| Researchers | 1,926 |
| ROR ID | https://ror.org/0234cd281 |
| Type | company |
| Works | 9,246 |

## University papers

Showing 12 of 18.

- [Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/safety-and-efficacy-of-edaravone-in-well-defined-patients-with-amyotrophic/)
- [Regulation of cell-cell contacts in developing Drosophila eyes by Dsrc41, a new, close relative of vertebrate c-src.](https://scholariq.org/papers/regulation-of-cell-cell-contacts-in-developing-drosophila-eyes-by-dsrc41-a-new/)
- [Long‐term edaravone efficacy in amyotrophic lateral sclerosis: Post‐hoc analyses of Study 19 (MCI186‐19)](https://scholariq.org/papers/long-term-edaravone-efficacy-in-amyotrophic-lateral-sclerosis-post-hoc-analyses/)
- [Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19](https://scholariq.org/papers/clinical-staging-in-amyotrophic-lateral-sclerosis-analysis-of-edaravone-study-19/)
- [An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the United States, and Europe](https://scholariq.org/papers/an-assessment-of-treatment-guidelines-clinical-practices-demographics-and/)
- [Post-hoc analysis of MCI186-17, the extension study to MCI186-16, the confirmatory double-blind, parallel-group, placebo-controlled study of edaravone in amyotrophic lateral sclerosis](https://scholariq.org/papers/post-hoc-analysis-of-mci186-17-the-extension-study-to-mci186-16-the-confirmatory/)
- [Post-hoc analysis of randomised, placebo-controlled, double-blind study (MCI186-19) of edaravone (MCI-186) in amyotrophic lateral sclerosis](https://scholariq.org/papers/post-hoc-analysis-of-randomised-placebo-controlled-double-blind-study-mci186-19/)
- [Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) \[clinical trial NCT01492686\]](https://scholariq.org/papers/edaravone-efficacy-in-amyotrophic-lateral-sclerosis-with-reduced-forced-vital/)
- [Oral edaravone demonstrated a favorable safety profile in patients with amyotrophic lateral sclerosis after 48 weeks of treatment](https://scholariq.org/papers/oral-edaravone-demonstrated-a-favorable-safety-profile-in-patients-with/)
- [Pharmacokinetics, Bioavailability, and Swallowing Safety With Riluzole Oral Film](https://scholariq.org/papers/pharmacokinetics-bioavailability-and-swallowing-safety-with-riluzole-oral-film/)
- [Post-hoc analysis of open-label extension period of study MCI186-19 in amyotrophic lateral sclerosis](https://scholariq.org/papers/post-hoc-analysis-of-open-label-extension-period-of-study-mci186-19-in/)
- [<i>Post-hoc</i> analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis](https://scholariq.org/papers/i-post-hoc-i-analyses-of-the-edaravone-clinical-trials-study-16-and-study-19-a/)

## University researchers

- [Fumihiro Takahashi](https://scholariq.org/researchers/fumihiro-takahashi/)
- [Stephen Apple](https://scholariq.org/researchers/stephen-apple/)

## University top topics

Showing 8 of 25.

- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)
- [Semiconductor materials and devices](https://scholariq.org/topics/semiconductor-materials-and-devices/)
- [Photonic and Optical Devices](https://scholariq.org/topics/photonic-and-optical-devices/)
- [Semiconductor Lasers and Optical Devices](https://scholariq.org/topics/semiconductor-lasers-and-optical-devices/)
- [Ion channel regulation and function](https://scholariq.org/topics/ion-channel-regulation-and-function/)
- [RNA and protein synthesis mechanisms](https://scholariq.org/topics/rna-and-protein-synthesis-mechanisms/)
- [Glycosylation and Glycoproteins Research](https://scholariq.org/topics/glycosylation-and-glycoproteins-research/)
- [Bacterial Genetics and Biotechnology](https://scholariq.org/topics/bacterial-genetics-and-biotechnology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.